VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1627488
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: my bowel movement has almost no smell; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (my bowel movement has almost no smell) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ANOSMIA (my bowel movement has almost no smell). At the time of the report, ANOSMIA (my bowel movement has almost no smell) outcome was unknown. Concomitant roduct use was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1627489
Sex: M
Age: 80
State: IL

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Sore Arm) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No medical history information was reported. Concomitant products included ATORVASTATIN, METOPROLOL, ASPIRIN [ACETYLSALICYLIC ACID], VITAMIN D3, MULTIVITAMIN [VITAMINS NOS] and FLUOROURACIL for an unknown indication. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced INJECTION SITE PAIN (Sore Arm). At the time of the report, INJECTION SITE PAIN (Sore Arm) outcome was unknown. No treatment medications were provided. Action taken with mRNA-1273 in response to the events was not applicable. This case was linked to MOD-2021-033059 (Patient Link).

Other Meds: ATORVASTATIN; METOPROLOL; ASPIRIN [ACETYLSALICYLIC ACID]; VITAMIN D3; MULTIVITAMIN [VITAMINS NOS]; FLUOROURACIL

Current Illness:

ID: 1627490
Sex: F
Age: 77
State: HI

Vax Date: 01/31/2021
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of pruritic rash (itchy rash on arm) and rash (itchy rash on back, stomach and waistline) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 030L20A) for COVID-19 immunization. No medical history reported. On Jan 31, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced pruritic rash (itchy rash on arm) and rash (itchy rash on back, stomach and waistline). Patient treated with triamcinolone 1% for rash. At the time of the report, pruritic rash (itchy rash on arm) and rash (itchy rash on back, stomach and waistline) outcome: unknown. Concomitant medication list not provided. Action taken with mRNA-1273 in response to events: not applicable. This case linked to MOD-2021-023725 (patient link).

Other Meds:

Current Illness:

ID: 1627491
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Pleurisy; This spontaneous case was reported by a consumer and describes the occurrence of PLEURISY (Pleurisy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PLEURISY (Pleurisy). The patient was treated with IBUPROFEN for Pleurisy, at an unspecified dose and frequency. At the time of the report, PLEURISY (Pleurisy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided. No concomitant medication was provided.

Other Meds:

Current Illness:

ID: 1627492
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: my bowel movement has almost no smell; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (my bowel movement has almost no smell) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ANOSMIA (my bowel movement has almost no smell). At the time of the report, ANOSMIA (my bowel movement has almost no smell) outcome was unknown. No concomitant medications were provided. No treatment medications were provided.

Other Meds:

Current Illness:

ID: 1627493
Sex: F
Age: 78
State: FL

Vax Date: 03/22/2021
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Only received one dose/ not received her second dose because she feels she missed the call to schedule; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Only received one dose/ not received her second dose because she feels she missed the call to schedule) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. Concurrent medical conditions included Arthritis (bad arthritis and would not move very well). On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Only received one dose/ not received her second dose because she feels she missed the call to schedule). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Only received one dose/ not received her second dose because she feels she missed the call to schedule) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported by the reporter. Treatment medication was not provided by the reporter. The patient did not have her second dose as of 02-Jul-2021. Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Follow up report received included information about current condition: The patient did not have any adverse event after first dose and was doing fine.

Other Meds:

Current Illness: Arthritis (bad arthritis and would not move very well)

ID: 1627494
Sex: F
Age:
State: WA

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: she has had serious problems with her feet and legs ever since; both of her feet and legs swelled up; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (she has had serious problems with her feet and legs ever since) and PERIPHERAL SWELLING (both of her feet and legs swelled up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (she has had serious problems with her feet and legs ever since) and PERIPHERAL SWELLING (both of her feet and legs swelled up). At the time of the report, LIMB DISCOMFORT (she has had serious problems with her feet and legs ever since) and PERIPHERAL SWELLING (both of her feet and legs swelled up) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was reported. Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Correspondence email letter - TCR received where Patient identifier (gender) and event has been reported.

Other Meds:

Current Illness:

ID: 1627495
Sex: M
Age: 80
State: NC

Vax Date: 02/03/2021
Onset Date: 02/03/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: big knot in throat, left of adams apple; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL DISCOMFORT (big knot in throat, left of adams apple) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination. No Medical History information was reported. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced OROPHARYNGEAL DISCOMFORT (big knot in throat, left of adams apple). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 06-Feb-2021, OROPHARYNGEAL DISCOMFORT (big knot in throat, left of adams apple) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. The Patient went to the Doctor and the doctor could not figure it out. No Concomitant medications were reported. The patient had taken steroid. This case was linked to MOD-2021-038759 (Patient Link). Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: On 03-May-2021, follow up document was attached in which the outcome of the events is recovered.

Other Meds:

Current Illness:

ID: 1627496
Sex: F
Age:
State: CA

Vax Date: 01/01/2021
Onset Date: 01/01/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Instant reaction to the vaccine; missed second dose-She was advised not to take the second dose of the moderna vaccine.; This spontaneous case was reported by a nurse and describes the occurrence of INJECTION RELATED REACTION (Instant reaction to the vaccine) and PRODUCT DOSE OMISSION ISSUE (missed second dose-She was advised not to take the second dose of the moderna vaccine.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced INJECTION RELATED REACTION (Instant reaction to the vaccine) and PRODUCT DOSE OMISSION ISSUE (missed second dose-She was advised not to take the second dose of the moderna vaccine.). At the time of the report, INJECTION RELATED REACTION (Instant reaction to the vaccine) outcome was unknown and PRODUCT DOSE OMISSION ISSUE (missed second dose-She was advised not to take the second dose of the moderna vaccine.) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient was advised not to take the second dose of the vaccine. Patient still wants to be vaccinated, and want s to know is she can take the Pfizer vaccine. No Concomitant medications reported. No treatment medications reported.

Other Meds:

Current Illness:

ID: 1627497
Sex: F
Age:
State: WA

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: she heard that 2 other people were sick after the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (she heard that 2 other people were sick after the vaccine) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ILLNESS (she heard that 2 other people were sick after the vaccine). At the time of the report, ILLNESS (she heard that 2 other people were sick after the vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment details were reported. Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: TCR received on 06-JUL-2021 to contact through mail ID provided, On 28-Jul-2021: Followup received included pt gender,age group and intials were updated.

Other Meds:

Current Illness:

ID: 1627498
Sex: M
Age: 42
State: TN

Vax Date: 12/30/2020
Onset Date: 12/30/2020
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Sore muscles; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore muscles) and PYREXIA (Fever) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 in 2020. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Dec-2020, the patient experienced MYALGIA (Sore muscles) and PYREXIA (Fever). The patient was treated with IBUPROFEN for Adverse event, at a dose of 1 UNK. At the time of the report, MYALGIA (Sore muscles) and PYREXIA (Fever) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. Concomitant medications included Flonase. This case was linked to MOD-2021-046419 (Patient Link).

Other Meds:

Current Illness:

ID: 1627499
Sex: F
Age:
State: MI

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: sick in stomach; slept all Sunday morning and all afternoon; Does not have the energy level she had prior Covid; vommitting; Extremely tired; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (sick in stomach), HYPERSOMNIA (slept all Sunday morning and all afternoon), ASTHENIA (Does not have the energy level she had prior Covid), VOMITING (vommitting) and FATIGUE (Extremely tired) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. No Medical History information was reported. On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (sick in stomach), HYPERSOMNIA (slept all Sunday morning and all afternoon), ASTHENIA (Does not have the energy level she had prior Covid), VOMITING (vommitting) and FATIGUE (Extremely tired). At the time of the report, ABDOMINAL DISCOMFORT (sick in stomach), HYPERSOMNIA (slept all Sunday morning and all afternoon), ASTHENIA (Does not have the energy level she had prior Covid), VOMITING (vommitting) and FATIGUE (Extremely tired) outcome was unknown. No Concomitant medication was provided by the Reporter. No Treatment Information was provided by the Reporter. he patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the mRNA-1273 in response to the events was not applicable.

Other Meds:

Current Illness:

ID: 1627500
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: dizzy; feel like throwing up; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy) and VOMITING (feel like throwing up) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizzy) and VOMITING (feel like throwing up). At the time of the report, DIZZINESS (dizzy) and VOMITING (feel like throwing up) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1627501
Sex: F
Age: 50
State:

Vax Date: 01/04/2021
Onset Date: 01/28/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Superficial vein thrombosis; weight gain; Runny nose; legs were shaking; Flushing; face, ears and chest began to become red; Pain on her arm/pain was in the same area she gets her IV infusion; This spontaneous case was reported by an other health care professional and describes the occurrence of THROMBOPHLEBITIS SUPERFICIAL (Superficial vein thrombosis), INFUSION SITE PAIN (Pain on her arm/pain was in the same area she gets her IV infusion), RHINORRHEA (Runny nose), TREMOR (legs were shaking) and FLUSHING (Flushing) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Co-suspect product included non-company product AGALSIDASE BETA for Fabry's disease. No Medical History information was reported. On 04-Jan-2021, the patient started AGALSIDASE BETA (Intravenous) 70 milligram every two weeks. On 17-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced RHINORRHEA (Runny nose), TREMOR (legs were shaking), FLUSHING (Flushing) and ERYTHEMA (face, ears and chest began to become red). On 15-Feb-2021, the patient experienced WEIGHT INCREASED (weight gain). In 2021, the patient experienced INFUSION SITE PAIN (Pain on her arm/pain was in the same area she gets her IV infusion). On an unknown date, the patient experienced THROMBOPHLEBITIS SUPERFICIAL (Superficial vein thrombosis). At the time of the report, THROMBOPHLEBITIS SUPERFICIAL (Superficial vein thrombosis) and INFUSION SITE PAIN (Pain on her arm/pain was in the same area she gets her IV infusion) was resolving, RHINORRHEA (Runny nose), TREMOR (legs were shaking), FLUSHING (Flushing) and ERYTHEMA (face, ears and chest began to become red) had resolved and WEIGHT INCREASED (weight gain) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not provided. Treatment Medication was not provided.

Other Meds:

Current Illness:

ID: 1627502
Sex: U
Age:
State: WA

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: she has had serious problems with her feet and legs ever since; both of her feet and legs swelled up; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (she has had serious problems with her feet and legs ever since) and PERIPHERAL SWELLING (both of her feet and legs swelled up) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (she has had serious problems with her feet and legs ever since) and PERIPHERAL SWELLING (both of her feet and legs swelled up). At the time of the report, LIMB DISCOMFORT (she has had serious problems with her feet and legs ever since) and PERIPHERAL SWELLING (both of her feet and legs swelled up) outcome was unknown. Concomitant medication were not provided. Treatment details were not provided. This case was linked to MOD-2021-219904 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Correspondence email response attached no new information

Other Meds:

Current Illness:

ID: 1627503
Sex: F
Age: 53
State: NY

Vax Date: 02/05/2021
Onset Date: 02/06/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: This spontaneous case was reported by an other health care professional and describes the occurrence of MYALGIA, HEADACHE and CHILLS in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. No Medical History information was reported. On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced MYALGIA, HEADACHE and CHILLS. The patient was treated with ACETAMINOPHEN ongoing from 06-Feb-2021 at an unspecified dose and frequency. On 07-Feb-2021, MYALGIA and CHILLS had resolved. On 09-Feb-2021, HEADACHE had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitants included medication for diabetes, hypertension medication, not specified. No treatment medications were reported. This case was linked to MOD-2021-031189 (Patient Link).

Other Meds:

Current Illness:

ID: 1627504
Sex: M
Age:
State: AZ

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: sore arm for about 4 days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm for about 4 days) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure high (under control), Sclerosis multiple (under control Patient goes in every 6 weeks for an infusion for his Multiple Sclerosis.) and Cholesterol (under control). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm for about 4 days). At the time of the report, PAIN IN EXTREMITY (sore arm for about 4 days) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication were high blood pressure, and high cholesterol for his Multiple Sclerosis. No treatment information was provided. This case was linked to MOD-2021-046071. Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up received on 14 JULY 2021 and event updated.

Other Meds:

Current Illness: Blood pressure high (under control); Cholesterol (under control); Sclerosis multiple (under control Patient goes in every 6 weeks for an infusion for his Multiple Sclerosis.)

ID: 1627505
Sex: F
Age: 33
State: AL

Vax Date: 04/29/2021
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Swollen Arm; Arm Hurt; Bruise at site of shot; muscle aches; Rash in arm; Body Chills; Nausea; Fever; This spontaneous case was reported by a patient and describes the occurrence of PERIPHERAL SWELLING (Swollen Arm), PAIN IN EXTREMITY (Arm Hurt), INJECTION SITE BRUISING (Bruise at site of shot), MYALGIA (muscle aches) and INJECTION SITE RASH (Rash in arm) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 001C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Hypersensitivity. Previously administered products included for an unreported indication: Influenza (reaction- high fever for several days, throwing up and body aches) in 2014. Concurrent medical conditions included Autoimmune hypothyroidism since 2018, Hashimoto's disease since 2018, Fatigue (Using energy med from doctor (started in last few weeks)) since 2020, Chronic sinusitis since 2008, Skin rash (Poison ivy spread and blistered over a month over both arms) since 04-Jun-2021, Skin rash (tick bite caused rash for up to 6 inches for about a week) since 28-May-2021, Drug allergy and Drug allergy. Concomitant products included ETHINYLESTRADIOL, NORGESTIMATE (ORTHO TRI-CYCLEN) for Birth control, LEVOTHYROXINE for Thyroid disorder NOS. On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Swollen Arm), PAIN IN EXTREMITY (Arm Hurt), INJECTION SITE BRUISING (Bruise at site of shot), MYALGIA (muscle aches), INJECTION SITE RASH (Rash in arm), CHILLS (Body Chills), NAUSEA (Nausea) and PYREXIA (Fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PERIPHERAL SWELLING (Swollen Arm), PAIN IN EXTREMITY (Arm Hurt), INJECTION SITE BRUISING (Bruise at site of shot), MYALGIA (muscle aches), INJECTION SITE RASH (Rash in arm), CHILLS (Body Chills), NAUSEA (Nausea) and PYREXIA (Fever) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Ice pack and cream for rash were used for treatment. This case was linked to MOD-2021-118796 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Non-Significant Follow up Appended - NNI.

Other Meds: LEVOTHYROXINE; ORTHO TRI-CYCLEN

Current Illness: Autoimmune hypothyroidism; Chronic sinusitis; Drug allergy; Fatigue (Using energy med from doctor (started in last few weeks)); Hashimoto's disease; Skin rash (tick bite caused rash for up to 6 inches for about a week); Skin rash (Poison ivy spread and blistered over a month over both arms)

ID: 1627506
Sex: F
Age: 64
State: FL

Vax Date: 03/18/2021
Onset Date: 05/12/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Hair thinning at the top of her head; Hair loss; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Hair loss) and ALOPECIA (Hair thinning at the top of her head) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination. No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, the patient experienced ALOPECIA (Hair loss). On an unknown date, the patient experienced ALOPECIA (Hair thinning at the top of her head). At the time of the report, ALOPECIA (Hair loss) and ALOPECIA (Hair thinning at the top of her head) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medication were not provided. Treatment medication were not provided.

Other Meds:

Current Illness:

ID: 1627507
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Arm was hot; slight headache; This spontaneous case was reported by a health care professional and describes the occurrence of INJECTION SITE WARMTH (Arm was hot) and HEADACHE (slight headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE WARMTH (Arm was hot) and HEADACHE (slight headache). At the time of the report, INJECTION SITE WARMTH (Arm was hot) and HEADACHE (slight headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication was not provided. Treatment medication was not provided. Patients were taking anti-anxiety medication. This case was linked to MOD-2021-041229, MOD-2021-041229.

Other Meds:

Current Illness:

ID: 1627508
Sex: F
Age: 63
State: NM

Vax Date: 03/30/2021
Onset Date: 03/30/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Extreme swollen lymph node; Hungry feel; Fatigued, Get tired; Nausea; Dizziness; Confusion; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Jun-2021 and was forwarded to Moderna on 02-Jun-2021. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), CONFUSIONAL STATE (Confusion), LYMPHADENOPATHY (Extreme swollen lymph node), HUNGER (Hungry feel) and FATIGUE (Fatigued, Get tired) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Penicillin allergy, Sulfonamide allergy and Drug allergy (Allergic to Iodine). Concomitant products included COLECALCIFEROL (VITAMIN D 3), UBIDECARENONE (COQ 10), GINKGO BILOBA and NATTOKINASE for an unknown indication. On 30-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced DIZZINESS (Dizziness), CONFUSIONAL STATE (Confusion) and NAUSEA (Nausea). On 01-Apr-2021, the patient experienced LYMPHADENOPATHY (Extreme swollen lymph node), HUNGER (Hungry feel) and FATIGUE (Fatigued, Get tired). At the time of the report, DIZZINESS (Dizziness), CONFUSIONAL STATE (Confusion), HUNGER (Hungry feel), FATIGUE (Fatigued, Get tired) and NAUSEA (Nausea) outcome was unknown and LYMPHADENOPATHY (Extreme swollen lymph node) had not resolved. Not Provided No treatment information was provided by reporter. This case was linked to MOD-2021-219973, MOD-2021-041181 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Additional Information has ADR form with patient medical history, conmed, 2nd dose ivaccine nformation,

Other Meds: VITAMIN D 3; COQ 10; GINKGO BILOBA; NATTOKINASE

Current Illness: Penicillin allergy; Sulfonamide allergy

ID: 1627509
Sex: U
Age:
State: AR

Vax Date: 03/27/2021
Onset Date: 06/02/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19), ILLNESS (has been sick) and HEAD DISCOMFORT (head congestion) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 046B21A) for COVID-19 vaccination. No Medical History information was reported. On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On 02-Jun-2021, the patient experienced ILLNESS (has been sick) and HEAD DISCOMFORT (head congestion). On 11-Jun-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) had not resolved and ILLNESS (has been sick) and HEAD DISCOMFORT (head congestion) was resolving. Concomitant medication information was not provided. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1627510
Sex: F
Age:
State: IL

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Limb Contusion; Pain of extremities; Headache; This spontaneous case was reported by a physician and describes the occurrence of CONTUSION (Limb Contusion), PAIN IN EXTREMITY (Pain of extremities) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Co-suspect product included non-company product ADALIMUMAB (HUMIRA) injection for Rheumatoid arthritis. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient experienced CONTUSION (Limb Contusion), PAIN IN EXTREMITY (Pain of extremities) and HEADACHE (Headache). At the time of the report, CONTUSION (Limb Contusion), PAIN IN EXTREMITY (Pain of extremities) and HEADACHE (Headache) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not provided. Treatment medication was not provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1627511
Sex: F
Age:
State:

Vax Date: 06/11/2021
Onset Date: 06/11/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Is dry mouth a side affect; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Is dry mouth a side affect) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jun-2021, the patient experienced DRY MOUTH (Is dry mouth a side affect). At the time of the report, DRY MOUTH (Is dry mouth a side affect) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1627512
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: hair loss; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (hair loss) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (hair loss). At the time of the report, ALOPECIA (hair loss) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (hair loss) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (hair loss). At the time of the report, ALOPECIA (hair loss) outcome was unknown. No concomitant medication was reported. Treatment medication was not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable. Reporter did not allow further contact Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1627513
Sex: F
Age: 15
State: TX

Vax Date: 06/11/2021
Onset Date: 06/11/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: 15 year old female who received her first dose of the Moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old female who received her first dose of the Moderna vaccine) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination. No Medical History information was reported. On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jun-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old female who received her first dose of the Moderna vaccine). On 11-Jun-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old female who received her first dose of the Moderna vaccine) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1627514
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Body Temperature Increased; Test Result: Inconclusive ; Result Unstructured Data: 98.8 F (normal is 97 F)

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: dry heaves; up all night; sever nausea; This spontaneous case was reported by a consumer and describes the occurrence of RETCHING (dry heaves), INSOMNIA (up all night) and NAUSEA (sever nausea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On an unknown date, the patient experienced RETCHING (dry heaves), INSOMNIA (up all night) and NAUSEA (sever nausea). At the time of the report, RETCHING (dry heaves), INSOMNIA (up all night) and NAUSEA (sever nausea) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature increased: 98.8 (Inconclusive) 98.8 F (normal is 97 F). No concomitant medication was reported. It was reported the patient was up all night due to severe nausea and dry heaves. No treatment medication was reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.

Other Meds:

Current Illness:

ID: 1627515
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: covid vaccine make it hard to breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (covid vaccine make it hard to breath) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (covid vaccine make it hard to breath). At the time of the report, DYSPNOEA (covid vaccine make it hard to breath) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were provided. No treatment information was provided. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1627516
Sex: F
Age: 33
State: TX

Vax Date: 06/11/2021
Onset Date: 06/11/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Band-aid fell off and they felt that it was wet; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE DISCHARGE (Band-aid fell off and they felt that it was wet) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009B21A) for COVID-19 vaccination. No Medical History information was reported. On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jun-2021, the patient experienced VACCINATION SITE DISCHARGE (Band-aid fell off and they felt that it was wet). At the time of the report, VACCINATION SITE DISCHARGE (Band-aid fell off and they felt that it was wet) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds:

Current Illness:

ID: 1627517
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: severe swelling of my feet and legs; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (severe swelling of my feet and legs) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (severe swelling of my feet and legs). At the time of the report, PERIPHERAL SWELLING (severe swelling of my feet and legs) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were provided by reporter. No treatment medications were reported.

Other Meds:

Current Illness:

ID: 1627518
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Lump under arm; Swelling under arm; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY MASS (Lump under arm) and PERIPHERAL SWELLING (Swelling under arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AXILLARY MASS (Lump under arm) and PERIPHERAL SWELLING (Swelling under arm). At the time of the report, AXILLARY MASS (Lump under arm) and PERIPHERAL SWELLING (Swelling under arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication were reported. No treatment information was reported Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1627519
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Body aches 2 weeks after 2nd shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches 2 weeks after 2nd shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (Body aches 2 weeks after 2nd shot). At the time of the report, MYALGIA (Body aches 2 weeks after 2nd shot) outcome was unknown. No concomitant medication were reported. No treatment information was reported.

Other Meds:

Current Illness:

ID: 1627520
Sex: F
Age: 67
State: CO

Vax Date: 02/26/2021
Onset Date: 03/19/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: dizziness; experiencing the rash and it's still itchy; took the first dose on 26Feb2021 and took her second dose on19March2021; fatigue; rash in left arm at the injection site that spread to right arm and leg; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), RASH PRURITIC (experiencing the rash and it's still itchy), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (took the first dose on 26Feb2021 and took her second dose on19March2021), FATIGUE (fatigue) and VACCINATION SITE RASH (rash in left arm at the injection site that spread to right arm and leg) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. EN6204 and EL9265) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure. Concomitant products included SIMVASTATIN for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Mar-2021, the patient experienced DIZZINESS (dizziness), RASH PRURITIC (experiencing the rash and it's still itchy), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (took the first dose on 26Feb2021 and took her second dose on19March2021), FATIGUE (fatigue) and VACCINATION SITE RASH (rash in left arm at the injection site that spread to right arm and leg). The patient was treated with TRIAMCINOLONE for Vaccination site rash and Itchy rash, at a dose of 1 dosage form. On 19-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (took the first dose on 26Feb2021 and took her second dose on19March2021) had resolved. At the time of the report, DIZZINESS (dizziness) and FATIGUE (fatigue) outcome was unknown and RASH PRURITIC (experiencing the rash and it's still itchy) and VACCINATION SITE RASH (rash in left arm at the injection site that spread to right arm and leg) had not resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. It was reported that the patient also took unspecified blood pressure medications and antidepressants.

Other Meds: SIMVASTATIN

Current Illness: Blood pressure

ID: 1627521
Sex: U
Age:
State:

Vax Date: 06/13/2021
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Flu symptoms after the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu symptoms after the 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (Flu symptoms after the 2nd dose). At the time of the report, INFLUENZA (Flu symptoms after the 2nd dose) outcome was unknown. No concomitant medications were reported. No treatment medications were reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1627522
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Flu with no fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA (Flu with no fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA (Flu with no fever). At the time of the report, INFLUENZA (Flu with no fever) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were mentioned. The patient was concerned if she should get the second dose if she still has the flu. No treatment details were reported.

Other Meds:

Current Illness:

ID: 1627523
Sex: F
Age: 38
State: WI

Vax Date: 06/13/2021
Onset Date: 06/13/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Patient was given dose from cracked vial; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Patient was given dose from cracked vial) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination. No Medical History information was reported. On 13-Jun-2021 at 10:30 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jun-2021, the patient experienced PRODUCT ADMINISTRATION ERROR (Patient was given dose from cracked vial). On 13-Jun-2021, PRODUCT ADMINISTRATION ERROR (Patient was given dose from cracked vial) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Relevant concomitant product usage were not reported by the reporter. No treatment details were added. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.

Other Meds:

Current Illness:

ID: 1627524
Sex: F
Age:
State: VA

Vax Date: 04/26/2021
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Extreme hair loss; arm was tender for the next 4 to 5 days; Arm was a little sore, little achy; Tired; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Extreme hair loss), TENDERNESS (arm was tender for the next 4 to 5 days), PAIN IN EXTREMITY (Arm was a little sore, little achy) and FATIGUE (Tired) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 050C21A and 016C21A) for COVID-19 vaccination. Concomitant products included ESTRADIOL (ESTROGEN) and PROGESTERONE for an unknown indication. On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ALOPECIA (Extreme hair loss), TENDERNESS (arm was tender for the next 4 to 5 days), PAIN IN EXTREMITY (Arm was a little sore, little achy) and FATIGUE (Tired). At the time of the report, ALOPECIA (Extreme hair loss) outcome was unknown and TENDERNESS (arm was tender for the next 4 to 5 days), PAIN IN EXTREMITY (Arm was a little sore, little achy) and FATIGUE (Tired) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medications also included hormone replacement therapy. The patient began experiencing extreme hair loss after the second dose which became extensive a week later after vaccination. She reported losing a handful of hair. Treatment information was not provided.

Other Meds: ESTROGEN; PROGESTERONE

Current Illness:

ID: 1627525
Sex: M
Age: 58
State: MA

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Antibody test; Result Unstructured Data: 2x antibody test that only show antibodies from Moderna and ZERO from any COVID exposure.; Test Name: Cardio/pulmonary test; Result Unstructured Data: I have had ever cardio/pulmonary test done with normal results consistent with past exams

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Prior to vaccination, average nightly sleep was 6 hours. Post vaccination experiencing 8-11 hours sleep.; Memory not as good; night chills; 24 hours of extreme body pain as if I pulled muscles in my back./Body Pain; experienced 24 hours of body aches/Body Aches; completely bedridden, unable to move; unable to move; extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Prior to vaccination, average nightly sleep was 6 hours. Post vaccination experiencing 8-11 hours sleep.), PAIN (24 hours of extreme body pain as if I pulled muscles in my back./Body Pain), BEDRIDDEN (completely bedridden, unable to move), MOBILITY DECREASED (unable to move) and MEMORY IMPAIRMENT (Memory not as good) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012LZOA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Hypercholesteraemia (High cholesterol), Gastroesophageal reflux disease, Blood pressure high (High blood pressure) and Type II diabetes mellitus (Type II Diabetes). Concomitant products included LOSARTAN for Blood pressure high, PANTOPRAZOLE for Gastroesophageal reflux disease, ATORVASTATIN for Hypercholesteraemia, METFORMIN and EMPAGLIFLOZIN (JARDIANCE) for Type II diabetes mellitus. On 14-Jan-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021 at 10:00 AM, the patient experienced FATIGUE (extreme fatigue). On 16-Jan-2021, the patient experienced BEDRIDDEN (completely bedridden, unable to move) and MOBILITY DECREASED (unable to move). On 26-Feb-2021, the patient experienced MYALGIA (experienced 24 hours of body aches/Body Aches). On 27-Feb-2021, the patient experienced PAIN (24 hours of extreme body pain as if I pulled muscles in my back./Body Pain). On an unknown date, the patient experienced HYPERSOMNIA (Prior to vaccination, average nightly sleep was 6 hours. Post vaccination experiencing 8-11 hours sleep.), MEMORY IMPAIRMENT (Memory not as good) and CHILLS (night chills). On 27-Feb-2021, MYALGIA (experienced 24 hours of body aches/Body Aches) had resolved with sequelae. On 28-Feb-2021, PAIN (24 hours of extreme body pain as if I pulled muscles in my back./Body Pain) had resolved with sequelae. At the time of the report, HYPERSOMNIA (Prior to vaccination, average nightly sleep was 6 hours. Post vaccination experiencing 8-11 hours sleep.), MEMORY IMPAIRMENT (Memory not as good) and CHILLS (night chills) outcome was unknown, BEDRIDDEN (completely bedridden, unable to move) and MOBILITY DECREASED (unable to move) had resolved and FATIGUE (extreme fatigue) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: normal (normal) 2x antibody test that only show antibodies from Moderna and ZERO from any COVID exposure.. On an unknown date, Cardiopulmonary exercise test: normal (normal) I have had ever cardio/pulmonary test done with normal results consistent with past exams. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment medications were provided by the reporter. Patient stated blood tests done rule out anything else. Prior to vaccination, the patient's average nightly sleep was 6 hours. Post vaccination, the patient experiencing experiencing 8-11 hours sleep Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Updated reporter's information, patient demographics, medical history,lab tests. Updated batch number, anatomical location of suspect drug,vaccine facility information. Added new concomitant medications. Updated chronic fatigue term to extreme fatigue, added start date and event outcome from unknown to not recovered. Added new events - body aches, body pain, completely bedridden, excessive sleepiness. On 04-Aug-2021: Patient demographics height and weight updated, Concurrent medical conditions addedConcomitant medication indication added, Events Night chills and Memory impairment added This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Prior to vaccination, average nightly sleep was 6 hours. Post vaccination experiencing 8-11 hours sleep.), PAIN (24 hours of extreme body pain as if I pulled muscles in my back./Body Pain), BEDRIDDEN (completely bedridden, unable to move), MOBILITY DECREASED (unable to move) and MEMORY IMPAIRMENT (Memory not as good) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012LZOA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Hypercholesteraemia (High cholesterol), Gastroesophageal reflux disease, Blood pressure high (High blood pressure) and Type II diabetes mellitus (Type II Diabetes). Concomitant products included LOSARTAN for Blood pressure high, PANTOPRAZOLE for Gastroesophageal reflux disease, ATORVASTATIN for Hypercholesteraemia, METFORMIN and EMPAGLIFLOZIN (JARDIANCE) for Type II diabetes mellitus. On 14-Jan-2021 at 10:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021 at 10:00 AM, the patient experienced FATIGUE (extreme fatigue). On 16-Jan-2021, the patient experienced BEDRIDDEN (completely bedridden, unable to move) and MOBILITY DECREASED (unable to move). On 26-Feb-2021, the patient experienced MYALGIA (experienced 24 hours of body aches/Body Aches). On 27-Feb-2021, the patient experienced PAIN (24 hours of extreme body pain as if I pulled muscles in my back./Body Pain). On an unknown date, the patient experienced HYPERSOMNIA (Prior to vaccination, average nightly sleep was 6 hours. Post vaccination experiencing 8-11 hours sleep.), MEMORY IMPAIRMENT (Memory not as good) and CHILLS (night chills). On 27-Feb-2021, MYALGIA (experienced 24 hours of body aches/Body Aches) had resolved with sequelae. On 28-Feb-2021, PAIN (24 hours of extreme body pain as if I pulled muscles in my back./Body Pain) had resolved with sequelae. At the time of the report, HYPERSOMNIA (Prior to vaccination, average nightly sleep was 6 hours. Post vaccination experiencing 8-11 hours sleep.), MEMORY IMPAIRMENT (Memory not as good) and CHILLS (night chills) outcome was unknown, BEDRIDDEN (completely bedridden, unable to move) and MOBILITY DECREASED (unable to move) had resolved and FATIGUE (extreme fatigue) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Antibody test: normal (normal) 2x antibody test that only show antibodies from Moderna and ZERO from any COVID exposure.. On an unknown date, Cardiopulmonary exercise test: normal (normal) I have had ever cardio/pulmonary test done with normal results consistent with past exams. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment medications were provided by the reporter. Patient stated blood tests done rule out anything else. Prior to vaccination, the patient's average nightly sleep was 6 hours. Post vaccination, the patient experiencing experiencing 8-11 hours sleep Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Updated reporter's information, patient demographics, medical history,lab tests. Updated batch number, anatomical location of suspect drug,vaccine facility information. Added new concomitant medications. Updated chronic fatigue term to extreme fatigue, added start date and event outcome from unknown to not recovered. Added new events - body aches, body pain, completely bedridden, excessive sleepiness. On 04-Aug-2021: Patient demographics height and weight updated, Concurrent medical conditions addedConcomitant medication indication

Other Meds: ATORVASTATIN; PANTOPRAZOLE; LOSARTAN; METFORMIN; JARDIANCE

Current Illness: Blood pressure high (High blood pressure); Gastroesophageal reflux disease; Hypercholesteraemia (High cholesterol); Type II diabetes mellitus (Type II Diabetes)

ID: 1627526
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: felt bad; shot site hah a rash and warmth.; shot site hah a rash; vaccination site erythema; Muscle pain; Chills; vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (felt bad), VACCINATION SITE WARMTH (shot site hah a rash and warmth.), VACCINATION SITE RASH (shot site hah a rash), VACCINATION SITE ERYTHEMA (vaccination site erythema) and MYALGIA (Muscle pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (felt bad), VACCINATION SITE WARMTH (shot site hah a rash and warmth.), VACCINATION SITE RASH (shot site hah a rash), VACCINATION SITE ERYTHEMA (vaccination site erythema), MYALGIA (Muscle pain), CHILLS (Chills) and VACCINATION SITE PAIN (vaccination site pain). At the time of the report, MALAISE (felt bad), VACCINATION SITE WARMTH (shot site hah a rash and warmth.), VACCINATION SITE RASH (shot site hah a rash), VACCINATION SITE ERYTHEMA (vaccination site erythema), MYALGIA (Muscle pain), CHILLS (Chills) and VACCINATION SITE PAIN (vaccination site pain) outcome was unknown. No concomitant medications was included. No treatment drug details was provided. I had an adverse reaction after my second dose and a week later had a relapse with a reaction at the injection site and I had pain at the injection site and chills and redness at the injection site. I felt as bad a week after as I did the 2nd day after my 2nd injection. This is information that should be shared with patients. I had to call my doctor. Most recent FOLLOW-UP information incorporated above includes: On 06-Jul-2021: Follow up information received, event vaccination site erythema added.

Other Meds:

Current Illness:

ID: 1627527
Sex: F
Age: 81
State: NJ

Vax Date: 04/22/2021
Onset Date: 05/20/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: not able to move legs for 6 hours after couple of hours of receiving the vaccine/ legs were not working 100 percent; felt sick; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (not able to move legs for 6 hours after couple of hours of receiving the vaccine/ legs were not working 100 percent) and ILLNESS (felt sick) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 20-May-2021, the patient experienced LIMB DISCOMFORT (not able to move legs for 6 hours after couple of hours of receiving the vaccine/ legs were not working 100 percent) and ILLNESS (felt sick). At the time of the report, LIMB DISCOMFORT (not able to move legs for 6 hours after couple of hours of receiving the vaccine/ legs were not working 100 percent) had not resolved and ILLNESS (felt sick) outcome was unknown. No concomitant medications were reported by the reporter. The patient reported that her legs were working, but not well and still had issues at the time of this report. Treatment medication was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1627528
Sex: M
Age: 39
State: NH

Vax Date: 04/29/2021
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210603; Test Name: Rapid COVID test; Test Result: Negative ; Result Unstructured Data: Negative

Allergies:

Symptom List: Pain in extremity

Symptoms: running nose; dry cough/ could not shake the dry cough/dry cough is so bad sometimes they cannot even speak even with cough drops; chest tightening, like a tight jacket that cannot be taken off/pressure in the chest; not to breathe properly/difficulty breathing /if their were breathing at 100% before the vaccination they are now breathing at 40%; sore throat are due to the excessive coughing.; experiencing a hard time lifting; asthma; allergies to pollen.; very tired/fatigue; fever; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (running nose), COUGH (dry cough/ could not shake the dry cough/dry cough is so bad sometimes they cannot even speak even with cough drops), CHEST DISCOMFORT (chest tightening, like a tight jacket that cannot be taken off/pressure in the chest), DYSPNOEA (not to breathe properly/difficulty breathing /if their were breathing at 100% before the vaccination they are now breathing at 40%) and OROPHARYNGEAL PAIN (sore throat are due to the excessive coughing.) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047C21A and 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (running nose), COUGH (dry cough/ could not shake the dry cough/dry cough is so bad sometimes they cannot even speak even with cough drops), CHEST DISCOMFORT (chest tightening, like a tight jacket that cannot be taken off/pressure in the chest), DYSPNOEA (not to breathe properly/difficulty breathing /if their were breathing at 100% before the vaccination they are now breathing at 40%), OROPHARYNGEAL PAIN (sore throat are due to the excessive coughing.), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (experiencing a hard time lifting), ASTHMA (asthma), SEASONAL ALLERGY (allergies to pollen.), FATIGUE (very tired/fatigue) and PYREXIA (fever). The patient was treated with AZITHROMYCIN ongoing since an unknown date for Cough and Nasopharyngitis, at a dose of 500 milligram; BENZONATATE ongoing since an unknown date for Cough, at a dose of 100 milligram and PREDNISONE ongoing since an unknown date for Asthma, at a dose of 20 milligram. At the time of the report, NASOPHARYNGITIS (running nose), COUGH (dry cough/ could not shake the dry cough/dry cough is so bad sometimes they cannot even speak even with cough drops), CHEST DISCOMFORT (chest tightening, like a tight jacket that cannot be taken off/pressure in the chest), DYSPNOEA (not to breathe properly/difficulty breathing /if their were breathing at 100% before the vaccination they are now breathing at 40%), OROPHARYNGEAL PAIN (sore throat are due to the excessive coughing.), LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (experiencing a hard time lifting), ASTHMA (asthma), SEASONAL ALLERGY (allergies to pollen.), FATIGUE (very tired/fatigue) and PYREXIA (fever) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Jun-2021, SARS-CoV-2 test: negative (Negative) Negative. HCP diagnosed patient with asthma and pollen allergy. Patient is confused by diagnosis as he has never had a history of allergies. Patient reported know improvement after taking treatment medications. No concomitant medications was provided by the reporter.

Other Meds:

Current Illness:

ID: 1627529
Sex: U
Age:
State:

Vax Date:
Onset Date: 06/10/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: fatigue,tired; headaches; feverish; chills; flu like symptoms; hot cold; dizziness; sick; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING OF BODY TEMPERATURE CHANGE (hot cold), DIZZINESS (dizziness), ILLNESS (sick) and FATIGUE (fatigue,tired) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Jun-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING OF BODY TEMPERATURE CHANGE (hot cold), DIZZINESS (dizziness), ILLNESS (sick), HEADACHE (headaches), PYREXIA (feverish) and CHILLS (chills). On an unknown date, the patient experienced FATIGUE (fatigue,tired). On 09-Jun-2021, FATIGUE (fatigue,tired) outcome was unknown. At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), FEELING OF BODY TEMPERATURE CHANGE (hot cold), DIZZINESS (dizziness), ILLNESS (sick), HEADACHE (headaches), PYREXIA (feverish) and CHILLS (chills) outcome was unknown. No concomitant medications were reported. No treatment medications were reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1627530
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: got really sick; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (got really sick) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (got really sick). At the time of the report, ILLNESS (got really sick) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1627531
Sex: F
Age: 76
State: MA

Vax Date: 04/26/2021
Onset Date: 04/26/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Chills after the 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills after the 1st dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination. The medical history was not provided by the reported. Concomitant products included ATENOLOL and LISINOPRIL for Blood pressure, SIMVASTATIN for Cholesterol, ACETYLSALICYLIC ACID (ASPIRIN), LEVOTHYROXINE SODIUM (SYNTHROID), OMEPRAZOLE and VITAMIN D NOS for an unknown indication. On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Apr-2021, the patient experienced CHILLS (Chills after the 1st dose). On 27-Apr-2021, CHILLS (Chills after the 1st dose) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. No information regarding treatment was provided.

Other Meds: ATENOLOL; LISINOPRIL; ASPIRIN; SYNTHROID; OMEPRAZOLE; VITAMIN D NOS; SIMVASTATIN

Current Illness:

ID: 1627532
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Side Effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side Effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side Effects). At the time of the report, VACCINATION COMPLICATION (Side Effects) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. No treatment medications were reported.

Other Meds:

Current Illness:

ID: 1627533
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of vaccination site warmth (the injection spot is warm), vaccination site swelling (the injection spot is swollen), vaccination site erythema (the injection spot is red) and vaccination site pain (the injection spot is very sore) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced vaccination site warmth (the injection spot is warm), vaccination site swelling (the injection spot is swollen), vaccination site erythema (the injection spot is red) and vaccination site pain (the injection spot is very sore). At the time of the report, vaccination site warmth (the injection spot is warm), vaccination site swelling (the injection spot is swollen), vaccination site erythema (the injection spot is red) and vaccination site pain (the injection spot is very sore) outcome: unknown. No concomitant medication or treatment information reported. Reporter did not allow further contact.

Other Meds:

Current Illness:

ID: 1627534
Sex: F
Age: 76
State: MA

Vax Date: 04/26/2021
Onset Date: 05/25/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Pins and needles /Tingling sensation in her left arm after the 2nd dose; Lips were really bright red after the 2nd dose; Cheeks got flushed and pink after the 2nd dose; Burning and discomfort in her left arm after her 2nd dose; Burning and discomfort in her left arm after her 2nd dose; Not feeling good after the 2nd dose; Feeling nauseous after the 2nd dose; Chills after the 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning and discomfort in her left arm after her 2nd dose), FEELING ABNORMAL (Not feeling good after the 2nd dose), PARAESTHESIA (Pins and needles /Tingling sensation in her left arm after the 2nd dose), LIP ERYTHEMA (Lips were really bright red after the 2nd dose) and FLUSHING (Cheeks got flushed and pink after the 2nd dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A and 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included ATENOLOL, LISINOPRIL, ACETYLSALICYLIC ACID (BABY ASPIRIN), LEVOTHYROXINE SODIUM (SYNTHROID), OMEPRAZOLE, COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) and SIMVASTATIN for an unknown indication. On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-May-2021, the patient experienced FEELING ABNORMAL (Not feeling good after the 2nd dose), NAUSEA (Feeling nauseous after the 2nd dose) and CHILLS (Chills after the 2nd dose). On 27-May-2021, the patient experienced BURNING SENSATION (Burning and discomfort in her left arm after her 2nd dose), PARAESTHESIA (Pins and needles /Tingling sensation in her left arm after the 2nd dose), LIP ERYTHEMA (Lips were really bright red after the 2nd dose), FLUSHING (Cheeks got flushed and pink after the 2nd dose) and LIMB DISCOMFORT (Burning and discomfort in her left arm after her 2nd dose). On 26-May-2021, FEELING ABNORMAL (Not feeling good after the 2nd dose), NAUSEA (Feeling nauseous after the 2nd dose) and CHILLS (Chills after the 2nd dose) had resolved. At the time of the report, BURNING SENSATION (Burning and discomfort in her left arm after her 2nd dose), PARAESTHESIA (Pins and needles /Tingling sensation in her left arm after the 2nd dose), LIP ERYTHEMA (Lips were really bright red after the 2nd dose), FLUSHING (Cheeks got flushed and pink after the 2nd dose) and LIMB DISCOMFORT (Burning and discomfort in her left arm after her 2nd dose) outcome was unknown. No treatment information provided.

Other Meds: ATENOLOL; LISINOPRIL; BABY ASPIRIN; SYNTHROID; OMEPRAZOLE; VITAMIN D [COLECALCIFEROL]; SIMVASTATIN

Current Illness:

ID: 1627535
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: heart rate; Result Unstructured Data: 105 heart rate to 136 for two days since getting 2nd shot.

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: heart rate increased; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (heart rate increased) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (heart rate increased). At the time of the report, HEART RATE INCREASED (heart rate increased) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Heart rate: 105 (High) 105 heart rate to 136 for two days since getting 2nd shot.. No treatment information was provided. No relevant concomitant medications were reported. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1627536
Sex: U
Age:
State:

Vax Date:
Onset Date: 06/14/2021
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: my arm is still sore; arm is still sore and its hot; now have a rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (my arm is still sore), VACCINATION SITE WARMTH (arm is still sore and its hot) and RASH (now have a rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, the patient experienced PAIN IN EXTREMITY (my arm is still sore), VACCINATION SITE WARMTH (arm is still sore and its hot) and RASH (now have a rash). At the time of the report, PAIN IN EXTREMITY (my arm is still sore), VACCINATION SITE WARMTH (arm is still sore and its hot) and RASH (now have a rash) had resolved. No concomitant medication was reported by the reporter. No treatment information provided. Most recent FOLLOW-UP information incorporated above includes: On 03-Aug-2021: follow up received: event outcome updated

Other Meds:

Current Illness:

ID: 1627537
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/24/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: This spontaneous case reported by a consumer, describes the occurrence of pyrexia (fever) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced pyrexia (fever). At the time of the report, pyrexia (fever) outcome: unknown. No concomitant medication or treatment information reported. Reporter did not allow further contact.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am